SWTX · Categories · Form 4

SWTX - SEC Form 4 insider transactions

SpringWorks Therapeutics Inc. (SWTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SWTX

• 336d
  Chief Operating Officer Edris Badreddin returned 169,712 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Lynch Daniel returned 93,004 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Lewis-Hall Freda C returned 24,727 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Hambleton Julie returned 14,155 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Fuhrman Alan returned 24,727 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Scientific Officer Lin Tai-An returned 33,039 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Commercial Officer Ashar Bhavesh returned 62,053 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Medical Officer Cassidy James returned 81,731 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Mackay Martin returned 20,023 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Director Alban Carlos returned 28,861 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Accounting Officer Nofi Michael returned 30,623 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief People Officer Pichl Daniel returned 50,762 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Financial Officer Perier Francis I Jr returned 60,889 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  Chief Executive Officer Islam Saqib returned 954,869 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 336d
  General Counsel & Secretary Weinstein Herschel S returned 55,239 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Lynch Daniel was granted 10,060 shares, increasing direct ownership by 12% to 93,004 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Lewis-Hall Freda C was granted 10,060 shares, increasing direct ownership by 69% to 24,727 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Hambleton Julie was granted 10,060 shares, increasing direct ownership by 246% to 14,155 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Fuhrman Alan was granted 10,060 shares, increasing direct ownership by 69% to 24,727 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Alban Carlos was granted 10,060 shares, increasing direct ownership by 54% to 28,861 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 384d
  Director Mackay Martin was granted 10,060 shares, increasing direct ownership by 101% to 20,023 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 455d
  Chief Operating Officer Edris Badreddin sold $1,084,592 worth of shares (20,000 units at $54.23), decreasing direct ownership by 11% to 169,712 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 455d
  Chief Executive Officer Islam Saqib covered exercise/tax liability with 30,756 shares and sold $2,657,656 worth of shares (49,000 units at $54.24), decreasing direct ownership by 8% to 954,869 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 464d
  Chief Executive Officer Islam Saqib sold $1,768,401 worth of shares (29,328 units at $60.30), decreasing direct ownership by 3% to 1,034,625 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 464d
  Chief Commercial Officer Ashar Bhavesh sold $62,168 worth of shares (1,016 units at $61.19), decreasing direct ownership by 2% to 62,053 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 464d
  Director Lynch Daniel sold $2,866,534 worth of shares (47,600 units at $60.22), decreasing direct ownership by 36% to 82,944 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 469d
  Chief Executive Officer Islam Saqib sold $639,490 worth of shares (10,672 units at $59.92), decreasing direct ownership by 0.99% to 1,063,953 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 469d
  Director Lynch Daniel sold $24,000 worth of shares (400 units at $60.00), decreasing direct ownership by 0.31% to 130,544 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 474d
  Chief Executive Officer Islam Saqib was granted 85,309 shares and covered exercise/tax liability with 13,186 shares, increasing direct ownership by 7% to 1,074,625 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 476d
  Chief People Officer Pichl Daniel exercised 29,750 shares at a strike of $27.64 and sold $1,617,329 worth of shares (29,750 units at $54.36) (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 476d
  Director Lynch Daniel sold $9,530,351 worth of shares (175,000 units at $54.46), decreasing direct ownership by 57% to 130,944 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 476d
  Chief Executive Officer Islam Saqib sold $2,558,237 worth of shares (48,000 units at $53.30), decreasing direct ownership by 5% to 1,002,502 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 476d
  Director Hambleton Julie exercised 13,774 shares at a strike of $32.27 and sold $730,207 worth of shares (13,774 units at $53.01) (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 476d
  Chief Operating Officer Edris Badreddin sold $1,593,795 worth of shares (30,000 units at $53.13), decreasing direct ownership by 14% to 189,712 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  General Counsel & Secretary Weinstein Herschel S was granted 12,126 shares, increasing direct ownership by 28% to 55,239 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief People Officer Pichl Daniel was granted 12,819 shares, increasing direct ownership by 34% to 50,762 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Financial Officer Perier Francis I Jr was granted 11,779 shares, increasing direct ownership by 24% to 60,889 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Accounting Officer Nofi Michael was granted 6,929 shares, increasing direct ownership by 29% to 30,623 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Scientific Officer Lin Tai-An was granted 6,929 shares, increasing direct ownership by 27% to 33,039 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Executive Officer Islam Saqib was granted 74,834 shares, increasing direct ownership by 8% to 1,050,502 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Operating Officer Edris Badreddin was granted 27,023 shares, increasing direct ownership by 14% to 219,712 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Medical Officer Cassidy James was granted 17,323 shares, increasing direct ownership by 27% to 81,731 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 505d
  Chief Commercial Officer Ashar Bhavesh was granted 17,323 shares, increasing direct ownership by 38% to 63,069 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Commercial Officer Ashar Bhavesh covered exercise/tax liability with 10,584 shares, decreasing direct ownership by 19% to 45,746 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  General Counsel & Secretary Weinstein Herschel S covered exercise/tax liability with 9,126 shares, decreasing direct ownership by 17% to 43,113 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief People Officer Pichl Daniel covered exercise/tax liability with 7,269 shares, decreasing direct ownership by 16% to 37,943 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Financial Officer Perier Francis I Jr covered exercise/tax liability with 10,143 shares, decreasing direct ownership by 17% to 49,110 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Accounting Officer Nofi Michael covered exercise/tax liability with 5,033 shares, decreasing direct ownership by 18% to 23,694 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Scientific Officer Lin Tai-An covered exercise/tax liability with 855 shares, decreasing direct ownership by 3% to 26,110 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Executive Officer Islam Saqib covered exercise/tax liability with 38,700 shares, decreasing direct ownership by 4% to 975,668 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Operating Officer Edris Badreddin covered exercise/tax liability with 16,911 shares, decreasing direct ownership by 8% to 192,689 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 512d
  Chief Medical Officer Cassidy James covered exercise/tax liability with 9,448 shares, decreasing direct ownership by 13% to 64,408 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 545d
  Chief Operating Officer Edris Badreddin sold $839,336 worth of shares (20,000 units at $41.97), decreasing direct ownership by 9% to 209,600 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 546d
  Chief Executive Officer Islam Saqib sold $2,027,357 worth of shares (49,000 units at $41.37), decreasing direct ownership by 5% to 1,014,368 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 608d
  Chief Scientific Officer Lin Tai-An covered exercise/tax liability with 2,324 shares, decreasing direct ownership by 8% to 26,965 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 637d
  Chief Executive Officer Islam Saqib sold $1,988,033 worth of shares (49,000 units at $40.57), decreasing direct ownership by 4% to 1,063,368 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 637d
  Chief Operating Officer Edris Badreddin sold $812,954 worth of shares (20,000 units at $40.65), decreasing direct ownership by 8% to 229,600 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 638d
  Chief Medical Officer Cassidy James covered exercise/tax liability with 1,969 shares, decreasing direct ownership by 3% to 73,856 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 673d
  Director Mackay Martin was granted 9,963 shares (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)
• 701d
  Chief Medical Officer Cassidy James covered exercise/tax liability with 591 shares, decreasing direct ownership by 0.77% to 75,825 units (SEC Form 4)

  4 - SpringWorks Therapeutics, Inc. (0001773427) (Issuer)

Other SWTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends